(Q46923243)

26 December 2017

title

L-Carnitine status in end-stage renal disease patients on automated peritoneal dialysis (English)

1 reference

26 December 2017

0 references

1 reference

Lorenzo Di Liberato

1

1 reference

26 December 2017

Arduino Arduini

2

1 reference

26 December 2017

Claudia Rossi

3

1 reference

26 December 2017

Augusto Di Castelnuovo

4

1 reference

26 December 2017

Cosima Posari

5

1 reference

26 December 2017

Paolo Sacchetta

6

1 reference

26 December 2017

Andrea Urbani

7

1 reference

26 December 2017

Mario Bonomini

8

1 reference

26 December 2017

publication date

6 March 2014

1 reference

26 December 2017

published in

Journal of Nephrology

1 reference

26 December 2017

volume

27

1 reference

26 December 2017

issue

6

1 reference

26 December 2017

page(s)

699-706

1 reference

26 December 2017

Carnitine, mitochondrial function and therapy

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Practice recommendations for the use of L-carnitine in dialysis-related carnitine disorder. National Kidney Foundation Carnitine Consensus Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Free and esterified carnitine in continuous ambulatory peritoneal dialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Carnitine status of pediatric patients on continuous ambulatory peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Carnitine supplementation improves apolipoprotein B levels in pediatric peritoneal dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Time course of peritoneal function in automated and continuous peritoneal dialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Biocompatible peritoneal dialysis solutions: do we have one?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Glucotoxicity in peritoneal dialysis--solutions for the solution!

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Measurement of stable isotopic enrichment and concentration of long-chain fatty acyl-carnitines in tissue by HPLC-MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

False-positive newborn screening mimicking glutaric aciduria type I in infants with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Serum metabolite concentrations and decreased GFR in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

The carnitine acyltransferases and their role in modulating acyl-CoA pools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Carnitine acyltransferases and their influence on CoA pools in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Intravenous L-carnitine increases plasma carnitine, reduces fatigue, and may preserve exercise capacity in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Carnitine in metabolic disease: potential for pharmacological intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Carnitine and carnitine esters in rat bile and human duodenal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Effect of an l-Carnitine–Containing Peritoneal Dialysate on Insulin Sensitivity in Patients Treated With CAPD: A 4-Month, Prospective, Multicenter Randomized Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40620-014-0076-X

Carnitine metabolism in uremia

21 January 2018

1 reference

12 December 2020

Serum carnitine levels, lipid profile, and metabolic status of patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Serum free carnitine, carnitine esters and lipids in patients on peritoneal dialysis and hemodialysis

1 reference

12 December 2020

Evaluation of carnitine levels according to the peritoneal equilibration test in patients on continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Carnitine--metabolism and functions

1 reference

12 December 2020

Effect of hemodialysis session on the dynamics of carnitine ester profile changes in L-carnitine pretreated end-stage renal disease patients

1 reference

12 December 2020

Total carnitine and acylated carnitine ratio: relationship of free carnitine with lipid parameters in pediatric dialysis patients.

1 reference

12 December 2020

Prevention of peritoneal sclerosis: a new proposal to substitute glucose with carnitine dialysis solution (biocompatibility testing in vitro and in rabbits).

1 reference

12 December 2020

Frequency of low carnitine levels in children on dialysis

1 reference

12 December 2020

Effect of carnitine supplementation on lipid profile and anemia in children on chronic dialysis

1 reference

12 December 2020

L-carnitine is an osmotic agent suitable for peritoneal dialysis

1 reference

12 December 2020

Continuous ambulatory peritoneal dialysis (CAPD) adequacy influences serum free carnitine level

1 reference

12 December 2020

Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprint

1 reference

12 December 2020

10.1007/S40620-014-0076-X

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017